{"id":"W2135417699","doi":"10.1086/650002","title":"Long‐Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment‐Experienced Patients with Drug‐Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials","year":2010,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Raltegravir; Medicine; Antiretroviral therapy; Internal medicine; Integrase inhibitor; Pharmacotherapy; Drug; Human immunodeficiency virus (HIV); Pharmacology; Viral load; Virology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001206565,0.0005349756,0.001501146,0.000246346,0.0002104905,0.000623355,0.0004794955,0.0005925766,0.001435187],"category_scores_gemma":[0.0009159668,0.0003103553,0.0007038601,0.0002479616,0.0003775769,0.0005797219,0.0002195948,0.001567687,0.0002721364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003694908,"about_ca_system_score_gemma":0.0003949853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003061602,"about_ca_topic_score_gemma":0.001196521,"domain_scores_codex":[0.9995097,0.0002888748,0.00003192608,0.00005456913,0.00004942894,0.00006544387],"domain_scores_gemma":[0.9994977,0.0001199601,0.0001420188,0.00004287538,0.00002747541,0.0001699381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.618381,0.03110464,0.008694476,0.001034083,0.002436833,0.0003336042,0.0002399391,0.003041294,0.0549902,0.0002583203,0.001743957,0.2777416],"study_design_scores_gemma":[0.3464483,0.5898989,0.04747626,0.0001205376,0.001346278,0.0006747732,0.00008480249,0.002277014,0.008094592,0.0001948677,0.003304963,0.00007860109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956971,0.002977261,0.0001894457,0.0001474066,0.0000249801,0.0001086967,0.0001417034,0.00003408123,0.0006792754],"genre_scores_gemma":[0.9970471,0.001182291,0.0005898666,0.0001821687,0.0000835261,0.0001230754,0.0003345082,0.00001024023,0.0004472726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001501146,"threshold_uncertainty_score":0.006380975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03522055684703406,"score_gpt":0.353666942293186,"score_spread":0.3184463854461519,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}